- Home
- RUMBW vs SNN Comparison
RUMBW vs SNN Comparison
Compare RUMBW & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RUMBW | SNN |
|---|---|---|
| Founded | 2013 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 12.3B |
| IPO Year | 2021 | 2002 |
Fundamental Metrics
Financial Performance| Metric | RUMBW | SNN |
|---|---|---|
| Price | $1.81 | $26.96 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $32.89 |
| AVG Volume (30 Days) | 11.7K | ★ 1.3M |
| Earning Date | 03-28-2025 | 08-04-2026 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | ★ 80.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $100,622,320.00 | N/A |
| Revenue This Year | N/A | $4.91 |
| Revenue Next Year | N/A | $5.26 |
| P/E Ratio | ★ N/A | $64.97 |
| Revenue Growth | ★ 5.38 | N/A |
| 52 Week Low | $0.76 | $26.38 |
| 52 Week High | $2.98 | $37.51 |
Technical Indicators
Market Signals| Indicator | RUMBW | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 45.46 | 37.99 |
| Support Level | $1.64 | N/A |
| Resistance Level | $1.83 | $31.36 |
| Average True Range (ATR) | 0.14 | 0.37 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 37.49 | 30.66 |
Price Performance
Historical ComparisonAbout RUMBW Rumble Inc. Warrant
RUM Group Inc focused is to maximize the power of human imagination through an independent technology ecosystem built on privacy, resilience, and an open alternative to Big Tech. Rumble gives human creativity a voice, a video and media platform built for creators and audiences who value free expression. Quake AI is a cloud and AI-infrastructure business, delivering the compute, data-center capacity, and blockchain infrastructure for the agentic era.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.